PRGO News and Press, Perrigo Company plc From 09/14/22

Argus Research upgraded OTC product maker Perrigo Company plc ( NYSE: PRGO ) to Buy from Hold, noting that the momentum PRGO saw in Q2, thanks to its focus on consumer self-care, could continue despite macro headwinds. While the company has faced the impact of industry-wide ...

Ireland-based pharma Perrigo Company plc ( NYSE: PRGO ) announced Monday that the FDA scheduled a meeting of its independent experts on Nov. 18 to decide on its marketing application for oral contraceptive Opill for Over-The-Counter (OTC) use. A progestin-only daily birth ...

PERRIGO ANNOUNCES JOINT FDA ADVISORY COMMITTEE TO REVIEW OPILL® DAILY ORAL CONTRACEPTIVE FOR OVER-THE-COUNTER (OTC) USE PR Newswire DUBLIN , Sept. 12, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care P...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Perrigo ( NYSE: PRGO ) Wednesday afternoon said that an August 16 notice of dismissal of claims and impending trial against the branded companies that manufactured Zantac (ranitidine) did not involve the company . Perrigo said that contrary to a news report, the plaint...

PERRIGO RELEASES STATEMENT ON RECENT MARKET TRADING ACTIVITY PR Newswire DUBLIN , Aug. 17, 2022 /PRNewswire/ -- In response to speculative commentary regarding ranitidine (Zantac ® ) litigation from a news story that contained certain misleading ...

Generic drugmakers Teva Pharmaceutical Industries ( NYSE: TEVA ) and Perrigo Company ( PRGO ) traded sharply lower on Wednesday after Bloomberg reported that the companies settled a lawsuit over the claims related to heartburn medication Zantac. Teva ( TEVA ) has rec...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...